KIYATEC Revenue and Competitors
Estimated Revenue & Valuation
- KIYATEC's estimated annual revenue is currently $4.1M per year.
- KIYATEC's estimated revenue per employee is $136,000
Employee Data
- KIYATEC has 30 Employees.
- KIYATEC grew their employee count by -3% last year.
KIYATEC's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Market Access & Reimbursement | Reveal Email/Phone |
4 | Human Resources Director | Reveal Email/Phone |
5 | Director R&D, Contract Services | Reveal Email/Phone |
6 | Director Research & Development - Immuno-oncology | Reveal Email/Phone |
7 | Chief Commercial Officer | Reveal Email/Phone |
8 | Chief Scientific Officer | Reveal Email/Phone |
9 | Communications Manager | Reveal Email/Phone |
10 | Clinical Affairs Scientist | Reveal Email/Phone |
KIYATEC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 16 | 14% | N/A | N/A |
#2 | $4.1M | 30 | -3% | N/A | N/A |
#3 | $0.7M | 18 | -22% | $5M | N/A |
#4 | $637.4M | 3073 | 5% | $264.2M | N/A |
What Is KIYATEC?
Wasted time is the enemy of cancer patients. KIYATEC's mission is to change the future of cancer care by accurately predicting patient-specific response and non-response before treatment begins. We utilize the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and the NCI. We are conducting robust clinical trials to fully demonstrate the power of our approach and earn widespread adoption for a broad portfolio of products predicting response to today's and tomorrow's therapies. www.kiyatec.com
keywords:N/AN/A
Total Funding
30
Number of Employees
$4.1M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
KIYATEC News
CORRECTING and REPLACING KIYATEC and ACCRF Joint Abstract at AACR Highlights Use of KIYA-PREDICT Drug Response Platform in ACC. CORRECTION by...
KIYATEC is a functional precision oncology company that measures the response of individual patient live cancer cells with its innovative 3D...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 30 | -12% | N/A |
#2 | $6.1M | 30 | 0% | N/A |
#3 | $5.4M | 30 | 3% | N/A |
#4 | $6.5M | 30 | 7% | N/A |
#5 | $2.4M | 30 | 3% | N/A |